Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 326

1.

The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.

D'Onofrio G, Panza F, Seripa D, Sancarlo D, Paris F, Cascavilla L, Urbano M, Gravina C, Fontana A, Solfrizzi V, Pellegrini F, Pilotto A.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1062-70. doi: 10.1002/gps.2644. Epub 2010 Oct 29.

PMID:
21905100
2.

Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.

Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.

Dement Geriatr Cogn Disord. 2007;23(5):327-33. Epub 2007 Mar 19.

PMID:
17374951
3.

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.

Panza F, Frisardi V, Seripa D, D'Onofrio G, Santamato A, Masullo C, Logroscino G, Solfrizzi V, Pilotto A.

Ageing Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7. Review.

PMID:
21763789
4.

Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.

Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P.

Acta Psychiatr Scand. 2006 Jan;113(1):59-63. Erratum in: Acta Psychiatr Scand. 2005 Dec;112(6):481.

PMID:
16390371
5.

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.

Dement Geriatr Cogn Disord. 2006;22(1):73-82. Epub 2006 May 12.

6.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
7.

Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.

Quaranta D, Bizzarro A, Marra C, Vita MG, Seripa D, Pilotto A, Sebastiani V, Mecocci P, Masullo C.

J Alzheimers Dis. 2009;16(1):173-80. doi: 10.3233/JAD-2009-0950.

PMID:
19158433
8.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
9.

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.

Martínez MF, Martín XE, Alcelay LG, Flores JC, Valiente JM, Juanbeltz BI, Beldarraín MA, López JM, Gonzalez-Fernández MC, Salazar AM, Gandarias RB, Borda SI, Marqués NO, Amillano MB, Zabaleta MC, de Pancorbo MM.

BMC Neurosci. 2009 Sep 30;10:125. doi: 10.1186/1471-2202-10-125.

10.

Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.

Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H.

J Neurol. 1999 Sep;246(9):821-4.

PMID:
10525981
11.

Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.

Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.

J Am Geriatr Soc. 2008 Apr;56(4):677-82. doi: 10.1111/j.1532-5415.2007.01606.x. Epub 2008 Jan 16.

PMID:
18205760
12.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
13.

Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans.

Jhoo JH, Kim KW, Lee DY, Lee KU, Lee JH, Kim SY, Youn JY, Youn JC, Woo JI.

J Neurol Sci. 2001 Feb 15;184(1):21-5.

PMID:
11231028
14.

Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.

D'Onofrio G, Sancarlo D, Panza F, Copetti M, Cascavilla L, Paris F, Seripa D, Matera MG, Solfrizzi V, Pellegrini F, Pilotto A.

Curr Alzheimer Res. 2012 Jul;9(6):759-71.

PMID:
22715983
15.

Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.

McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.

Neurosci Lett. 2010 Oct 8;483(1):62-6. doi: 10.1016/j.neulet.2010.07.063. Epub 2010 Aug 1.

PMID:
20678545
16.

APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.

Huriletemuer, Wang B, Wang J, Wang G, Zhang C, Zhao S, Zhou S, Ma X, Wang de S.

J Neurol Sci. 2010 Jan 15;288(1-2):167-9. doi: 10.1016/j.jns.2009.08.058. Epub 2009 Oct 12.

PMID:
19819468
17.

Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.

Kamruecha W, Chansirikarnjana S, Nimkulrat E, Udommongkol C, Wongmek W, Thangnipon W.

Southeast Asian J Trop Med Public Health. 2006 Jul;37(4):793-7.

PMID:
17121308
18.

Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.

Kim HC, Kim DK, Choi IJ, Kang KH, Yi SD, Park J, Park YN.

Psychiatry Clin Neurosci. 2001 Apr;55(2):115-20.

19.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
20.

Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population.

Baron M, Jimenez-Escrig A, Orensanz L, Simon J, Perez-Tur J.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):121-4.

PMID:
12815750

Supplemental Content

Support Center